Literature DB >> 24847763

Toll-like receptors and B cells: functions and mechanisms.

Claire M Buchta1, Gail A Bishop.   

Abstract

Numerous reports have described Toll-like receptor (TLR) functions in myeloid cells such as dendritic cells (DCs) and macrophages, but relatively fewer studies have examined TLR responses in B lymphocytes. B cells express a wide variety of TLRs and are highly activated after TLR ligation, leading to enhancements in B cell survival, surface molecule expression, cytokine and antibody production, and antigen presentation. During an immune response, B cells can receive signals through TLRs as well as the B cell antigen receptor (BCR) and/or CD40. TLR ligation synergizes with signals through these receptors and augments both innate and adaptive immune functions of B lymphocytes. Additionally, targeting B cell TLRs may provide new therapies against certain types of cancer as well as autoimmune diseases. Here, we summarize TLR expression and contributions to both normal and pathogenic functions in mouse and human B cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24847763     DOI: 10.1007/s12026-014-8523-2

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  168 in total

1.  Oncogenically active MYD88 mutations in human lymphoma.

Authors:  Vu N Ngo; Ryan M Young; Roland Schmitz; Sameer Jhavar; Wenming Xiao; Kian-Huat Lim; Holger Kohlhammer; Weihong Xu; Yandan Yang; Hong Zhao; Arthur L Shaffer; Paul Romesser; George Wright; John Powell; Andreas Rosenwald; Hans Konrad Muller-Hermelink; German Ott; Randy D Gascoyne; Joseph M Connors; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Richard I Fisher; Rita M Braziel; Raymond R Tubbs; J R Cook; Denny D Weisenburger; Wing C Chan; Louis M Staudt
Journal:  Nature       Date:  2010-12-22       Impact factor: 49.962

2.  TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848).

Authors:  Risini D Weeratna; Shawn R Makinen; Michael J McCluskie; Heather L Davis
Journal:  Vaccine       Date:  2005-07-18       Impact factor: 3.641

3.  CpG drives human transitional B cells to terminal differentiation and production of natural antibodies.

Authors:  Federica Capolunghi; Simona Cascioli; Ezio Giorda; Maria Manuela Rosado; Alessandro Plebani; Cinzia Auriti; Giulio Seganti; Roberta Zuntini; Simona Ferrari; Maria Cagliuso; Isabella Quinti; Rita Carsetti
Journal:  J Immunol       Date:  2008-01-15       Impact factor: 5.422

4.  Cutting Edge: Importance of IL-6 and cooperation between innate and adaptive immune receptors in cellular vaccination with B lymphocytes.

Authors:  Tony J Vanden Bush; Claire M Buchta; Jennifer Claudio; Gail A Bishop
Journal:  J Immunol       Date:  2009-10-15       Impact factor: 5.422

5.  Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia.

Authors:  Xose S Puente; Magda Pinyol; Víctor Quesada; Laura Conde; Gonzalo R Ordóñez; Neus Villamor; Georgia Escaramis; Pedro Jares; Sílvia Beà; Marcos González-Díaz; Laia Bassaganyas; Tycho Baumann; Manel Juan; Mónica López-Guerra; Dolors Colomer; José M C Tubío; Cristina López; Alba Navarro; Cristian Tornador; Marta Aymerich; María Rozman; Jesús M Hernández; Diana A Puente; José M P Freije; Gloria Velasco; Ana Gutiérrez-Fernández; Dolors Costa; Anna Carrió; Sara Guijarro; Anna Enjuanes; Lluís Hernández; Jordi Yagüe; Pilar Nicolás; Carlos M Romeo-Casabona; Heinz Himmelbauer; Ester Castillo; Juliane C Dohm; Silvia de Sanjosé; Miguel A Piris; Enrique de Alava; Jesús San Miguel; Romina Royo; Josep L Gelpí; David Torrents; Modesto Orozco; David G Pisano; Alfonso Valencia; Roderic Guigó; Mónica Bayés; Simon Heath; Marta Gut; Peter Klatt; John Marshall; Keiran Raine; Lucy A Stebbings; P Andrew Futreal; Michael R Stratton; Peter J Campbell; Ivo Gut; Armando López-Guillermo; Xavier Estivill; Emili Montserrat; Carlos López-Otín; Elías Campo
Journal:  Nature       Date:  2011-06-05       Impact factor: 49.962

6.  Role of TLR in B cell development: signaling through TLR4 promotes B cell maturation and is inhibited by TLR2.

Authors:  Elize A Hayashi; Shizuo Akira; Alberto Nobrega
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

7.  Adoptive transfer of tumor reactive B cells confers host T-cell immunity and tumor regression.

Authors:  Qiao Li; Xiangming Lao; Qin Pan; Ning Ning; Ji Yet; Yingxin Xu; Shengping Li; Alfred E Chang
Journal:  Clin Cancer Res       Date:  2011-06-20       Impact factor: 12.531

8.  Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help.

Authors:  Hendrik Poeck; Moritz Wagner; Julia Battiany; Simon Rothenfusser; Daniela Wellisch; Veit Hornung; Bernd Jahrsdorfer; Thomas Giese; Stefan Endres; Gunther Hartmann
Journal:  Blood       Date:  2003-12-30       Impact factor: 22.113

9.  Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.

Authors:  G J Freeman; J G Gribben; V A Boussiotis; J W Ng; V A Restivo; L A Lombard; G S Gray; L M Nadler
Journal:  Science       Date:  1993-11-05       Impact factor: 47.728

10.  Antigen receptor signals rescue B cells from TLR tolerance.

Authors:  Jayakumar S Poovassery; Tony J Vanden Bush; Gail A Bishop
Journal:  J Immunol       Date:  2009-07-31       Impact factor: 5.422

View more
  28 in total

1.  Regulation of humoral immunity by gut microbial products.

Authors:  Myunghoo Kim; Chang H Kim
Journal:  Gut Microbes       Date:  2017-02-28

2.  Gut Microbial Metabolites Fuel Host Antibody Responses.

Authors:  Myunghoo Kim; Yaqing Qie; Jeongho Park; Chang H Kim
Journal:  Cell Host Microbe       Date:  2016-07-28       Impact factor: 21.023

3.  Expression of Toll-Like Receptor 2 by Dendritic Cells Is Essential for the DnaJ-ΔA146Ply-Mediated Th1 Immune Response against Streptococcus pneumoniae.

Authors:  Xiaofang Wang; Taixian Yuan; Jun Yuan; Yufeng Su; Xiaoyu Sun; Jingwen Wu; Hong Zhang; Xun Min; Xuemei Zhang; Yibing Yin
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

Review 4.  Therapeutic applications of toll-like receptors (TLRs) agonists in AML.

Authors:  Ye Peng; Yanzhong Wang; Manling Wang; Jianping Lan; Yirui Chen
Journal:  Clin Transl Oncol       Date:  2022-08-13       Impact factor: 3.340

Review 5.  The potential of the microbiota to influence vaccine responses.

Authors:  David J Lynn; Bali Pulendran
Journal:  J Leukoc Biol       Date:  2017-12-28       Impact factor: 4.962

Review 6.  Genetics of Lupus Nephritis: Clinical Implications.

Authors:  Melissa E Munroe; Judith A James
Journal:  Semin Nephrol       Date:  2015-09       Impact factor: 5.299

Review 7.  Toll-like receptors, triggering receptor expressed on myeloid cells family members and receptor for advanced glycation end-products in allergic airway inflammation.

Authors:  Sannette C Hall; Devendra K Agrawal
Journal:  Expert Rev Respir Med       Date:  2016-01-20       Impact factor: 3.772

8.  Functional Analysis of the Transcriptional Regulator IκB-ζ in Intestinal Homeostasis.

Authors:  Tomoki Sasaki; Hiroyuki Nagashima; Atsushi Okuma; Takeshi Yamauchi; Kenshi Yamasaki; Setsuya Aiba; Takanori So; Naoto Ishii; Yuji Owada; Takashi MaruYama; Shuhei Kobayashi
Journal:  Dig Dis Sci       Date:  2021-04-05       Impact factor: 3.199

Review 9.  Toll-Like Receptor-Based Strategies for Cancer Immunotherapy.

Authors:  Saghar Pahlavanneshan; Ali Sayadmanesh; Hamidreza Ebrahimiyan; Mohsen Basiri
Journal:  J Immunol Res       Date:  2021-05-22       Impact factor: 4.818

10.  Evaluation of Alpha-Ketoglutarate Supplementation on the Improvement of Intestinal Antioxidant Capacity and Immune Response in Songpu Mirror Carp (Cyprinus carpio) After Infection With Aeromonas hydrophila.

Authors:  Di Wu; Ze Fan; Jinnan Li; Yuanyuan Zhang; Chang'an Wang; Qiyou Xu; Liansheng Wang
Journal:  Front Immunol       Date:  2021-06-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.